These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15905461)

  • 1. COX-2-derived prostacyclin modulates vascular remodeling.
    Rudic RD; Brinster D; Cheng Y; Fries S; Song WL; Austin S; Coffman TM; FitzGerald GA
    Circ Res; 2005 Jun; 96(12):1240-7. PubMed ID: 15905461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of prostacyclin in the cardiovascular response to thromboxane A2.
    Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA
    Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.
    Egan KM; Wang M; Fries S; Lucitt MB; Zukas AM; Puré E; Lawson JA; FitzGerald GA
    Circulation; 2005 Jan; 111(3):334-42. PubMed ID: 15655126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2-derived prostacyclin confers atheroprotection on female mice.
    Egan KM; Lawson JA; Fries S; Koller B; Rader DJ; Smyth EM; Fitzgerald GA
    Science; 2004 Dec; 306(5703):1954-7. PubMed ID: 15550624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.
    Kearney D; Byrne A; Crean P; Cox D; Fitzgerald DJ
    J Am Coll Cardiol; 2004 Feb; 43(4):526-31. PubMed ID: 14975458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
    Belton OA; Duffy A; Toomey S; Fitzgerald DJ
    Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors.
    Eskildsen MP; Hansen PB; Stubbe J; Toft A; Walter S; Marcussen N; Rasmussen LM; Vanhoutte PM; Jensen BL
    Hypertension; 2014 Sep; 64(3):551-6. PubMed ID: 24914192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2-derived endogenous prostacyclin enhances mouse embryo hatching.
    Huang JC; Wun WS; Goldsby JS; Matijevic-Aleksic N; Wu KK
    Hum Reprod; 2004 Dec; 19(12):2900-6. PubMed ID: 15489241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of cyclooxygenase-2 and prostacyclin/IP receptors in mucosal defense against ischemia/reperfusion injury in mouse stomach.
    Kotani T; Kobata A; Nakamura E; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2006 Feb; 316(2):547-55. PubMed ID: 16236816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oviduct prostacyclin functions as a paracrine factor to augment the development of embryos.
    Huang JC; Goldsby JS; Arbab F; Melhem Z; Aleksic N; Wu KK
    Hum Reprod; 2004 Dec; 19(12):2907-12. PubMed ID: 15492023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vasoconstrictor role for cyclooxygenase-1-mediated prostacyclin synthesis in mouse renal arteries.
    Liu B; Zhang Y; Zhu N; Li H; Luo W; Zhou Y
    Am J Physiol Renal Physiol; 2013 Nov; 305(9):F1315-22. PubMed ID: 23986518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen stimulation of COX-2-derived PGI2 confers atheroprotection.
    Shah BH
    Trends Endocrinol Metab; 2005 Jul; 16(5):199-201. PubMed ID: 15950485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2-dependent cardiac failure in Gh/tTG transgenic mice.
    Zhang Z; Vezza R; Plappert T; McNamara P; Lawson JA; Austin S; Praticò D; Sutton MS; FitzGerald GA
    Circ Res; 2003 May; 92(10):1153-61. PubMed ID: 12702643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclo-oxygenase products and atherothrombosis.
    FitzGerald GA; Austin S; Egan K; Cheng Y; Pratico D
    Ann Med; 2000 Dec; 32 Suppl 1():21-6. PubMed ID: 11209977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP.
    Fujino T; Nakagawa N; Yuhki K; Hara A; Yamada T; Takayama K; Kuriyama S; Hosoki Y; Takahata O; Taniguchi T; Fukuzawa J; Hasebe N; Kikuchi K; Narumiya S; Ushikubi F
    J Clin Invest; 2004 Sep; 114(6):805-12. PubMed ID: 15372104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 and inflammation in atherosclerosis.
    Linton MF; Fazio S
    Curr Opin Pharmacol; 2004 Apr; 4(2):116-23. PubMed ID: 15063354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 inhibitors and metabolism of essential fatty acids.
    Das UN
    Med Sci Monit; 2005 Jul; 11(7):RA233-7. PubMed ID: 15990700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specific cyclo-oxygenase-2 inhibitors in cardiovascular pathology].
    Monsuez JJ
    Arch Mal Coeur Vaiss; 2004 Jun; 97(6):632-40. PubMed ID: 15283037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin protects against elevated blood pressure and cardiac fibrosis.
    Francois H; Athirakul K; Howell D; Dash R; Mao L; Kim HS; Rockman HA; Fitzgerald GA; Koller BH; Coffman TM
    Cell Metab; 2005 Sep; 2(3):201-7. PubMed ID: 16154102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cyclooxygenase-2 and EP3 prostaglandin receptor in acute herpetic but not postherpetic pain in mice.
    Takasaki I; Nojima H; Shiraki K; Sugimoto Y; Ichikawa A; Ushikubi F; Narumiya S; Kuraishi Y
    Neuropharmacology; 2005 Sep; 49(3):283-92. PubMed ID: 15925391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.